Furthermore, NanoISD induces proinflammatory cytokine production, prompts the maturation of antigen presenting cells, promotes the tumor infiltration of NK cells and CD8+ T cells, reduces tumor burden, and enhances responses to ICB therapy. This evidence concerns the gene CD8A and neoplasm.